Phenytoin Antibody (Mouse Monoclonal)

• Description:

  Mouse Phenytoin Antibody (Monoclonal). 6 different clones are available._x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

  Catalog #	A2010005-1E5_x000D_ _x000D_ A2010005-4D8_x000D_ _x000D_ A2010005-8H9_x000D_ _x000D_ A2010005-2C6_x000D_ _x000D_ A2010005-5H7_x000D_ _x000D_ A2010005-9F3_x000D_ _x000D_ A2010005-SET
  Size	0.25 mg
  Other Names	Mab to Phenytoin, antibody to Phenytoin
  Host	Mouse
  Concentration	1.0 mg/mL
  Purity	>90% (protein A column)
  Storage	-20°C. Avoid repeated freeze/thaw cycles.
  Supplied as	Liquid solution
  Buffer	1X Phosphate Buffer Saline, pH 7.4 + 0.05% sodium azide.
  Keywords	Phenytoin, mouse monoclonal antibody

  _x000D_  _x000D_ _x000D_ References_x000D_

  _x000D_
  • Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action. Keppel Hesselink JM, Kopsky DJ. J Neurol. 2017 Aug;264(8):1617-1621.
  _x000D_
  • Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs. DeToledo JC, Ramsay RE. Drug Saf. 2000 Jun;22(6):459-66.
  _x000D_
  • Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity. Kamp H, Fabian E, Groeters S, Herold M, Krennrich G, Looser R, Mattes W, Mellert W, Prokoudine A, Ruiz-Noppinger P, Strauss V, Walk T, Wiemer J, van Ravenzwaay B. Bioanalysis. 2012 Sep;4(18):2291-301.
  _x000D_
  • Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration. Johnson GJ, Kilpatrick CJ, Bury RW, Fullinfaw RO, Moulds RF. Br J Clin Pharmacol. 1989 Jun;27(6):843-9.
  _x000D_
  • Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): pharmacokinetics in patients following intravenous and intramuscular administration. Boucher BA, Bombassaro AM, Rasmussen SN, Watridge CB, Achari R, Turlapaty P. J Pharm Sci. 1989 Nov;78(11):929-32.
  _x000D_
  • Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit. Muchohi SN, Kokwaro GO, Maitho TE, Munenge RW, Watkins WM, Edwards G. Eur J Drug Metab Pharmacokinet. 2002 Apr-Jun;27(2):83-9.
  _x000D_
  • Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats. Burstein AH, Cox DS, Mistry B, Eddington ND. Epilepsy Res. 1999 Apr;34(2-3):129-33.
  _x000D_
  • Phenytoin as an effective treatment for polymorphic ventricular tachycardia due to QT prolongation in a patient with multiple drug intolerances. Yager N, Wang K, Keshwani N, Torosoff M. BMJ Case Rep. 2015 Jun 12;2015:bcr2015209521.
  _x000D_

• Short Description:

  Catalog #: A2010005 - 0.25 mg_x000D_ _x000D_ _x000D_ Mouse monoclonal antibody to phenytoin (a drug used to treat seizures, heart arrhythmia, and neuropathic pain). Six clones are available: 1E5, 4D8, 8H9, 2C6, 5H7 and 9F3. Antibodies can be used in ELISA formats as a well as western blot and other immuno-detection methods. Bulk pricing and biotinylation services are available. Live Enquiry about this product via Text/SMS: 1-858-900-3210 (8 am €“ 8 pm PST)._x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

  Clone	Catalog #
  1E5	A2010005-1E5
  4D8	A2010005-4D8
  8H9	A2010005-8H9
  2C6	A2010005-2C6
  5H7	A2010005-5H7
  9F3	A2010005-9F3
  6-Clone Set	A2010005-SET

• Weight:

  32

• Length:

  8

• Width:

  6.75

• Height :

  5.5

• CAS Number:

  9007-83-4